The Innovation&Transfer Fund of Peking University Third Hospital for their financial support under grant number BYSYCY2024085.
Objective:This study aimed to investigate the accuracy of needle insertion and dosimetric parameters in three-dimensional printing template(3D-PT)-assisted computed tomography(CT)-guided radioactive iodine-125(125I)se...
BACKGROUND Radioactive iodine-125(125I)microparticle therapy is a new type of internal radiation therapy that has shown unique advantages in the treatment of malignant tumors,especially hepatocellular carcinoma.Patien...
Malignant tumors are major causes of morbidity and mortality in China.Despite advances in surgical,radiological,chemotherapeutic,molecular targeting,and immunotherapeutic treatments,patients with malignant tumors stil...
This work was supported by grants from the National Natural Science Foundation of China(Nos.81873920,81571774);the High-Level University Clinical Research Promotion Program of Guangzhou Medical University(No.B185004019);the Science and Technology Project of Guangzhou(No.202002030135);the Medical Science and Technology Research Foundation of Guangdong Province(Nos.A2019187,B2019055,and B2019089)。
To the Editor:Portal vein tumor thrombus(PVTT)is present in 10%to 40%of patients with hepatocellular carcinoma(HCC)at diagnosis and has a profound adverse effect on progno-sis.[1]Sorafenib is recommended as the first-...
Objectives: To explore the clinical efficacy and survival of CT-guided Iodine-125 radioactive seed implantation in the treatment of stage Ⅳ primary hepatocellular carcinoma.Methods: A retrospective study of 62 patien...
Supported by the Guangzhou Huadu District Science and Technology Project(No.20-HDWS-054).
This case report describes a patient with advanced gallbladder cancer who developed septic shock associated with iodine-125(^(125)I)seed implantation.The treatment process is described to provide a clinical reference ...
BACKGROUND Malignant obstructive jaundice is mainly caused by cholangiocarcinoma.Only a few patients are indicated for surgical resection,and the 3-year survival rate is<50%.For patients who are not eligible for surge...
Supported by National Natural Science Foundation of China(No.81570891);Beijing Natural Science Foundation(No.7151003)。
AIM: To measure the concentration of vascular endothelial growth factor-A(VEGF-A), and placental growth factor(PLGF) in aqueous humor of uveal melanoma patients before and after Iodine-125 plaque therapy(IPT), determi...
the Beijing Municipal Science and Technology Commission project,the Capital of the Public Health Cultivation-Transcatheter Implantation combined with TACE/TAE in the treatment of portal vein tumor thrombus in clinical research,No.Z171100000417031
BACKGROUND Main portal vein tumor thrombus(MPVTT), which has a high incidence, is the major complication of terminal liver cancer. The occurrence of MPVTT is always a negative prognostic factor for patients with hepat...
Supported by the Beijing Municipal Science and Technology Commission project;the Capital of the Public Health Cultivation-Transcatheter active particles implantation combined with TACE/TAE in the treatment of portal vein tumor thrombus in clinical research,No.Z171100000417031
AIM To evaluate the efficacy of main portal vein stents combined with iodine-125(^(125)Ⅰ) to treat main portal vein tumor thrombus.METHODS From January 1, 2010 to January 1, 2015, 111 patients were diagnosed with liv...